MED25 Gene CMT2B2 Genetic Test
Cost: AED 4400.0
Test Components
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for MED25 Gene CMT2B2 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with MED25 Gene CMT2B2
Test Details
The MED25 gene is associated with CMT2B2, a subtype of Charcot-Marie-Tooth disease (CMT) that is characterized by progressive weakness and atrophy of the muscles in the feet and lower legs. CMT2B2 is caused by mutations in the MED25 gene, which provides instructions for making a protein that is involved in the regulation of gene expression.
NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once using advanced sequencing technology. NGS genetic testing can be used to identify mutations in the MED25 gene that are associated with CMT2B2.
NGS genetic testing for CMT2B2 may be recommended for individuals with symptoms of CMT, such as muscle weakness, atrophy, and sensory loss in the feet and lower legs. It may also be recommended for individuals with a family history of CMT or a known mutation in the MED25 gene.
The results of NGS genetic testing for CMT2B2 can help diagnose the condition and guide treatment and management decisions. There is currently no cure for CMT, but early diagnosis and management can help improve quality of life and slow the progression of the disease.
Test Name | MED25 Gene CMT2B2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MED25 Gene CMT2B2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MED25 Gene CMT2B2 |
Test Details |
The MED25 gene is associated with CMT2B2, a subtype of Charcot-Marie-Tooth disease (CMT) that is characterized by progressive weakness and atrophy of the muscles in the feet and lower legs. CMT2B2 is caused by mutations in the MED25 gene, which provides instructions for making a protein that is involved in the regulation of gene expression. NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once using advanced sequencing technology. NGS genetic testing can be used to identify mutations in the MED25 gene that are associated with CMT2B2. NGS genetic testing for CMT2B2 may be recommended for individuals with symptoms of CMT, such as muscle weakness, atrophy, and sensory loss in the feet and lower legs. It may also be recommended for individuals with a family history of CMT or a known mutation in the MED25 gene. The results of NGS genetic testing for CMT2B2 can help diagnose the condition and guide treatment and management decisions. There is currently no cure for CMT, but early diagnosis and management can help improve quality of life and slow the progression of the disease. |